Cardiovascular Toxicity and Management of Targeted Cancer Therapy: An Overview for Generalists
The advent of effective oral, molecular-targeted drugs in oncology has changed many incurable malignancies such as chronic myeloid leukemia into chronic diseases similar to coronary artery disease and diabetes mellitus. Oral agents including monoclonal antibodies, kinase inhibitors and hormone recep...
Main Authors: | Bossaer, John B., Geraci, Stephen A., Chakraborty, Kanishka |
---|---|
Published: |
Digital Commons @ East Tennessee State University
2016
|
Subjects: | |
Online Access: | https://dc.etsu.edu/etsu-works/2324 https://doi.org/10.1016/j.amjms.2016.02.023 |
Similar Items
-
Oncology Pharmacy: Community Pharmacy Implications
by: Bossaer, John B.
Published: (2011) -
Olanzapine for Chemotherapy-Induced Nausea and Vomiting
by: Bossaer, John B.
Published: (2016) -
Don’t Get Fooled Again: Evaluating New Oral Oncolytics for Drug Interactions
by: Bossaer, John B.
Published: (2018) -
Low Rate of Cetuximab Hypersensitivity Reactions in Northeast Tennessee: An Appalachian Effect?
by: Adams, Brooke C., et al.
Published: (2015) -
Thyroid Dysfunction with Targeted Chemotherapy Agents
by: Bossaer, John B.
Published: (2012)